TLSI
TriSalus Life Sciences, Inc.
- Latest sale
- $1k
- May 15 · No plan
- Form 4 sales
- 13
- On record
- Form 144 notices
- 1
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planMay 19 2025
Sold 4,764 shares at $5.18 ($25k)
Devlin Jodi, Chief of Clinical Operations
No 10b5-1 planSold 8.3% of holdings ($298k position)52,764 shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planMay 19 same day
Sold 4,764 shares at $5.18 ($25k)
Cox Bryan F., Chief of Research
No 10b5-1 planSold 3.8% of holdings ($643k position)119,415 shares leftFiling
- 3 Form 4 saleNo planMar 16 +301 days
Sold 3,530 shares at $4.11 ($15k)
Stevens Jennifer, Chief Regulatory Officer
No 10b5-1 planSold 2.8% of holdings ($525k position)124,110 shares leftFiling
- 4 Form 4 saleNo planMar 16 same day
Sold 3,457 shares at $4.11 ($14k)
Marshak Richard, Chief Commercial Officer
No 10b5-1 planSold 3% of holdings ($468k position)110,397 shares leftFiling
- 5 Form 4 saleNo planMar 16 same day
Sold 3,184 shares at $4.11 ($13k)
Cox Bryan F., Chief of Research
No 10b5-1 planSold 1.9% of holdings ($685k position)163,415 shares leftFiling
- 6 Form 4 saleNo planMar 16 same day
Sold 3,207 shares at $4.11 ($13k)
Devlin Jodi, Chief of Clinical Operations
No 10b5-1 planSold 3.2% of holdings ($413k position)97,364 shares leftFiling
- 7 Form 4 saleNo planMar 17 +1 day
Sold 20,302 shares at $3.91 ($79k)
Szela Mary T, CEO and President
No 10b5-1 planSold 2.6% of holdings ($3M position)752,987 shares leftFirst sale on recordFiling
- 8 Form 4 saleNo planMay 15 +59 days
Sold 543 shares at $2.67 ($1k)
Marshak Richard, Chief Commercial Officer
No 10b5-1 planSold 0.4% of holdings ($335k position)125,101 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (14)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Marshak Richard | Chief Commercial Officer | Form 4 sale | 543 | $1k | 0.4% | No plan | SEC |
| Mar 17, 2026 | Szela Mary T | CEO and President | Form 4 sale | 20,302 | $79k | 2.6% | No plan | SEC |
| Mar 16, 2026 | Devlin Jodi | Chief of Clinical Operations | Form 4 sale | 3,207 | $13k | 3.2% | No plan | SEC |
| Mar 16, 2026 | Cox Bryan F. | Chief of Research | Form 4 sale | 3,184 | $13k | 1.9% | No plan | SEC |
| Mar 16, 2026 | Marshak Richard | Chief Commercial Officer | Form 4 sale | 3,457 | $14k | 3.0% | No plan | SEC |
| Mar 16, 2026 | Stevens Jennifer | Chief Regulatory Officer | Form 4 sale | 3,530 | $15k | 2.8% | No plan | SEC |
| May 19, 2025 | Cox Bryan F. | Chief of Research | Form 4 sale | 4,764 | $25k | 3.8% | No plan | SEC |
| May 19, 2025 | Devlin Jodi | Chief of Clinical Operations | Form 4 sale | 4,764 | $25k | 8.3% | No plan | SEC |
| May 19, 2025 | Marshak Richard | Chief Commercial Officer | Form 4 sale | 6,597 | $34k | 8.7% | No plan | SEC |
| May 19, 2025 | Stevens Jennifer | Chief Regulatory Officer | Form 4 sale | 8,704 | $45k | 10.1% | No plan | SEC |
| Dec 10, 2024 | Desai Arjun JJ | Director | Form 4 sale | 30,000 | $111k | 10.8% | No plan | SEC |
| Dec 10, 2024 | Desai Arjun JJ | Board of Directors | Form 144 notice | 30,000 | $135k | Notice | SEC | |
| Oct 5, 2024 | Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. | Form 4 sale | 314 | $1k | 0.4% | No plan | SEC |
| Aug 28, 2024 | Martin George Kelly | Director | Form 4 sale | 9 | $50 | 0.0% | No plan | SEC |